According to Dr. Reddy's's latest financial reports the company's total liabilities are $1.26 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-03-31 | $1.10 B | -17.97% |
2022-03-31 | $1.34 B | 7.2% |
2021-03-31 | $1.25 B | 22.83% |
2020-03-31 | $1.02 B | -16.54% |
2019-03-31 | $1.22 B | -19.39% |
2018-03-31 | $1.52 B | 3.01% |
2017-03-31 | $1.47 B | 23.7% |
2016-03-31 | $1.19 B | -10.49% |
2015-03-31 | $1.33 B | 0.6% |
2014-03-31 | $1.32 B | 3.56% |
2013-03-31 | $1.28 B | 5.1% |
2012-03-31 | $1.21 B | 10.99% |
2011-03-31 | $1.09 B | 31.56% |
2010-03-31 | $0.83 B | 1.59% |
2009-03-31 | $0.82 B | -14.35% |
2008-03-31 | $0.95 B | -6.75% |
2007-03-31 | $1.02 B | -1.69% |
2006-03-31 | $1.04 B | 447.74% |
2005-03-31 | $0.19 B | 48.11% |
2004-03-31 | $0.12 B | 153.35% |
2003-03-31 | $50.93 M | 21.16% |
2002-03-31 | $42.03 M | -46.9% |
2001-03-31 | $79.17 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Novartis NVS | $53.19 B | 4,117.84% | ๐จ๐ญ Switzerland |
Pfizer PFE | $137.21 B | 10,779.65% | ๐บ๐ธ USA |
Sanofi SNY | $57.61 B | 4,468.15% | ๐ซ๐ท France |
GlaxoSmithKline GSK | $58.82 B | 4,564.27% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $35.35 B | 2,703.15% | ๐ฎ๐ฑ Israel |